Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Pharma Native ApS
APS
Active
Reklamebeskyttelse
CVR 44114976
Ravnehusvej 10C, 3500
Værløse
Computer consultancy and computer facilities management activities
·
NACE 6220
Est. 2023 · 3 years old
2 employees
www-pharma-native.com
Overvåg
Share
Denmark
/
Companies
/
Computer consultancy and computer facilities management activities
/
Pharma Native ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
1M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2023
2024
2025
Gross profit
849
1.538
990
Staff expenses
-489
-1.432
-826
EBITDA
359
106
163
Depreciation & amort.
-0
-0
-0
EBIT
359
106
163
Net financials
-9
-5
-4
Profit before tax
350
101
159
Tax
78
23
35
Net profit
271
77
124
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
632
444
386
Equity
311
267
256
Long-term debt
0
0
0
Short-term debt
320
177
130
Total debt
320
177
130
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
16.5%
This company
2023
2025
Soliditetsgrad
66.3%
This company
38.2%
Market median
+74% vs market
2023
2025
Egenkapitalforrentning
48.4%
This company
18.4%
Market median
+163% vs market
2023
2025
Nettoresultatgrad (af bruttofortjeneste)
12.5%
This company
2023
2025
Aktivomsætning (af bruttofortjeneste)
2.56×
This company
2023
2025
Gæld/egenkapital
0.51×
This company
0.62×
Market median
+18% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-06-12 – 2023-12-31
View
PDF
More on Pharma Native ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
